22 October 2020>: Clinical Research
Serum Levels of Gamma-Glutamyltransferase During Stable and Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Desheng Sun 12ABCEG* , Hongyan Liu 3DF , Yao Ouyang 1B , Xiansheng Liu 2G , Yongjian Xu 2CDOI: 10.12659/MSM.927771
Med Sci Monit 2020; 26:e927771
Table 1 Demographic and clinical characteristics of all the subjects. Data are shown as mean±SD or number (percentage).
Characteristics | Control subjects (n=112) | Stable COPD (n=107) | AECOPD (n=117) |
---|---|---|---|
Sex, Male/Female | 58/54 | 57/50 | 60/57 |
Age, y | 60.1±10.2 | 62.8±11.2 | 65.4±9.8 |
BMI, kg/m | 23.2±3.5 | 22.3±3.3 | 22.3±3.7 |
Smoking status, never/former/current | 37/35/40 | 39/30/38 | 40/41/36 |
FVC, L | 2.6±0.9 | 2.9±1.1 | 2.1±0.9 |
FEV, L | 2.2±0.7 | 1.7±0.6* | 1.1±0.6# |
FEV, % | 87.8±9.8 | 71.2±10.5* | 46.5±12.7# |
FEV/FVC (%) | 81.2±6.3 | 59.7±8.7* | 53.7±12.3# |
Hypertension, n (%) | 30 (25.2) | 29 (25.7) | 34 (28.6) |
Heart failure, n (%) | 3 (2.5) | 4 (3.5) | 4 (3.4) |
Coronary heart disease, n (%) | 11 (9.2) | 11 (9.7) | 12 (10.1) |
BUN, mmol/L | 5.3±2.9 | 5.7±1.7 | 5.8±1.8 |
Creatinine, μmol/L | 75.7 | 15.6 | 76.2 |
AST, IU/L | 22.4±5.5 | 21.1±4.6 | 23.5±7.5 |
ALT, IU/L | 16.6±5.7 | 17.5 ±7.5 | 19.4 ±8.6 |
Total bilirubin, μmol/L | 9.8±3.5 | 10.5 ±5.7 | 10.3 ±4.4 |
* # |